NO20000519L - 2-acylaminopropanaminer som takykininreseptorantagonister - Google Patents
2-acylaminopropanaminer som takykininreseptorantagonisterInfo
- Publication number
- NO20000519L NO20000519L NO20000519A NO20000519A NO20000519L NO 20000519 L NO20000519 L NO 20000519L NO 20000519 A NO20000519 A NO 20000519A NO 20000519 A NO20000519 A NO 20000519A NO 20000519 L NO20000519 L NO 20000519L
- Authority
- NO
- Norway
- Prior art keywords
- receptor antagonists
- acylaminopropanamines
- tachykinin receptor
- tachykinin
- acylaminopropanamine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C07D209/16—Tryptamines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5499797P | 1997-08-06 | 1997-08-06 | |
| PCT/US1998/016333 WO1999007677A1 (fr) | 1997-08-06 | 1998-08-06 | 2-acylaminopropanamines utiles en tant qu'antagonistes du recepteur de tachykinine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20000519D0 NO20000519D0 (no) | 2000-02-01 |
| NO20000519L true NO20000519L (no) | 2000-03-31 |
Family
ID=21994906
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20000519A NO20000519L (no) | 1997-08-06 | 2000-02-01 | 2-acylaminopropanaminer som takykininreseptorantagonister |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6358994B1 (fr) |
| EP (1) | EP1005454A4 (fr) |
| JP (1) | JP2001512715A (fr) |
| KR (1) | KR20010022581A (fr) |
| CN (1) | CN1272842A (fr) |
| AU (1) | AU8693398A (fr) |
| BR (1) | BR9811821A (fr) |
| CA (1) | CA2298701A1 (fr) |
| EA (1) | EA200000198A1 (fr) |
| HR (1) | HRP20000065A2 (fr) |
| HU (1) | HUP0002929A3 (fr) |
| ID (1) | ID24468A (fr) |
| IL (1) | IL134301A0 (fr) |
| NO (1) | NO20000519L (fr) |
| PL (1) | PL338453A1 (fr) |
| TR (1) | TR200000291T2 (fr) |
| WO (1) | WO1999007677A1 (fr) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR9811819A (pt) * | 1997-08-06 | 2000-08-15 | Lilly Co Eli | 2-acilaminopropanaminas como antagonistas receptores de taquicinina |
| DE60210760T2 (de) * | 2001-04-23 | 2006-11-23 | F. Hoffmann-La Roche Ag | Verwendung von nk-1-rezeptorantagonisten gegen benigne prostatahyperplasie |
| CA2483159C (fr) | 2002-04-26 | 2010-08-10 | Eli Lilly And Company | Derives de triazole en tant qu'antagonistes des recepteurs de la tachykinine |
| MXPA04010625A (es) * | 2002-04-26 | 2004-12-13 | Lilly Co Eli | Antagonista de receptor de taquicinina. |
| TW200616967A (en) | 2004-06-24 | 2006-06-01 | Smithkline Beecham Corp | Novel indazole carboxamides and their use |
| NZ563687A (en) * | 2005-06-30 | 2011-07-29 | Smithkline Beecham Corp | 3-[1-(ethylsulfonyl)-4-piperidinyl]-5-[2-(1-methylethyl)-2,3-dihydro-1H-isoindol-5-yl]-1H-indole-7-carboxamide for inhibiting IKK2 (aka IKKbeta) |
| US8063071B2 (en) | 2007-10-31 | 2011-11-22 | GlaxoSmithKline, LLC | Chemical compounds |
| US8093268B2 (en) | 2007-01-24 | 2012-01-10 | Glaxo Group Limited | Pharmaceutical compositions comprising 2-methoxy-5-(5-trifluoromethyl-tetrazol-1-yl-benzyl)-(2S-phenylpiperidin-3S-yl-) |
| AR065804A1 (es) | 2007-03-23 | 2009-07-01 | Smithkline Beecham Corp | Compuesto de indol carboxamida, composicion farmaceutica que lo comprende y uso de dicho compuesto para preparar un medicamento |
| WO2010102968A1 (fr) | 2009-03-10 | 2010-09-16 | Glaxo Group Limited | Dérivés d'indole comme inhibiteurs de ikk2 |
| WO2011104307A2 (fr) * | 2010-02-25 | 2011-09-01 | Graffinity Pharmaceuticals Gmbh | Ligands destinés à la purification d'anticorps par chromatographie d'affinité |
| CN105906608B (zh) * | 2016-05-03 | 2018-10-19 | 中山大学 | 8-氨基喹啉-松果体素杂联体及其药物组合物 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1340588C (fr) | 1988-06-13 | 1999-06-08 | Balraj Krishan Handa | Derive d'aminoacides |
| US5278316A (en) * | 1989-06-29 | 1994-01-11 | Warner-Lambert Company | N-substituted cycloalkyl and polycycloalkyl alpha-substituted Trp-Phe- and phenethylamine derivatives |
| AU687754B2 (en) | 1990-08-31 | 1998-03-05 | Warner-Lambert Company | Tachykinin antagonists |
| EP0919245A3 (fr) | 1991-09-20 | 2000-11-15 | Glaxo Group Limited | Un recepteurs antagoniste NK-1 et un corticosteroide antiinflammatoire systemique, pour le traitement des vomissements |
| US5328927A (en) * | 1992-03-03 | 1994-07-12 | Merck Sharpe & Dohme, Ltd. | Hetercyclic compounds, processes for their preparation and pharmaceutical compositions containing them |
| US5612336A (en) * | 1992-07-13 | 1997-03-18 | Merck, Sharp & Dohme Ltd. | Heterocyclic amide derivatives as tachykinin antagonists |
| US5554627A (en) | 1992-10-30 | 1996-09-10 | Merck, Sharp & Dohme Ltd. | Tachykinin antagonists |
| US6403577B1 (en) * | 1993-11-17 | 2002-06-11 | Eli Lilly And Company | Hexamethyleneiminyl tachykinin receptor antagonists |
| US5491140A (en) | 1994-06-30 | 1996-02-13 | Eli Lilly And Company | Naphthyl tachykinin receptor antagonists to treat physiological conditions |
| MX9700271A (es) | 1994-07-12 | 1997-05-31 | Lilly Co Eli | Antagonistas heterociclicos del receptor de taquinicina. |
-
1998
- 1998-08-06 TR TR2000/00291T patent/TR200000291T2/xx unknown
- 1998-08-06 PL PL98338453A patent/PL338453A1/xx unknown
- 1998-08-06 JP JP2000506181A patent/JP2001512715A/ja not_active Withdrawn
- 1998-08-06 EA EA200000198A patent/EA200000198A1/ru unknown
- 1998-08-06 CA CA002298701A patent/CA2298701A1/fr not_active Abandoned
- 1998-08-06 BR BR9811821-8A patent/BR9811821A/pt not_active Application Discontinuation
- 1998-08-06 KR KR1020007001172A patent/KR20010022581A/ko not_active Application Discontinuation
- 1998-08-06 ID IDW20000220A patent/ID24468A/id unknown
- 1998-08-06 WO PCT/US1998/016333 patent/WO1999007677A1/fr not_active Application Discontinuation
- 1998-08-06 CN CN98809800A patent/CN1272842A/zh active Pending
- 1998-08-06 HU HU0002929A patent/HUP0002929A3/hu unknown
- 1998-08-06 US US09/463,855 patent/US6358994B1/en not_active Expired - Fee Related
- 1998-08-06 IL IL13430198A patent/IL134301A0/xx unknown
- 1998-08-06 EP EP98938403A patent/EP1005454A4/fr not_active Withdrawn
- 1998-08-06 AU AU86933/98A patent/AU8693398A/en not_active Abandoned
-
2000
- 2000-02-01 NO NO20000519A patent/NO20000519L/no not_active Application Discontinuation
- 2000-02-04 HR HR20000065A patent/HRP20000065A2/hr not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IL134301A0 (en) | 2001-04-30 |
| JP2001512715A (ja) | 2001-08-28 |
| KR20010022581A (ko) | 2001-03-26 |
| EA200000198A1 (ru) | 2000-10-30 |
| EP1005454A1 (fr) | 2000-06-07 |
| HUP0002929A2 (hu) | 2001-10-28 |
| ID24468A (id) | 2000-07-20 |
| CN1272842A (zh) | 2000-11-08 |
| WO1999007677A1 (fr) | 1999-02-18 |
| TR200000291T2 (tr) | 2000-07-21 |
| HRP20000065A2 (en) | 2001-04-30 |
| BR9811821A (pt) | 2000-08-15 |
| EP1005454A4 (fr) | 2003-01-15 |
| CA2298701A1 (fr) | 1999-02-18 |
| AU8693398A (en) | 1999-03-01 |
| HUP0002929A3 (en) | 2002-01-28 |
| US6358994B1 (en) | 2002-03-19 |
| PL338453A1 (en) | 2000-11-06 |
| NO20000519D0 (no) | 2000-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ITRM960810A0 (it) | Composizioni farmaceutiche contenenti ciclosporine o macrolidi | |
| NO20004803L (no) | Smilagening og anzurogenin for behandling av Alzheimers sykdom | |
| DZ2494A1 (fr) | Composition pharmaceutique d'oméprazole. | |
| ID28003A (id) | Turunan-turunan adamantana | |
| NO972451L (no) | Heterosyklyloksy- og tiometyl-1,2,5-tiadiazolidin-3-on 1,1-dioksyder og preparater og fremgangsmåte for anvendelse derav | |
| MY118151A (en) | Pharmaceutical formulations containing voriconazole. | |
| DZ3191A1 (fr) | Composés d'indazole et compositions pharmaceutiques inhibant les protéines kinases, et procédés d'utilisation de ceux-ci. | |
| NO965377D0 (no) | Indolinonforbindelser samt farmasöytiske preparater inneholdende forbindelsene | |
| DE60209929D1 (de) | Succinate des 5,8,14-triazatetracycloä10.3.1.0 2,11 .0 4,9 ü-hexadeca-2(11),3,5,7,9,-pentaens und pharmazeutische zusammensetzungen | |
| EE200100179A (et) | Farmatseutilised agendid Parkinsoni tõve, ADHD jamikroadenoomide raviks | |
| NO972391D0 (no) | 2-substituerte 1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav | |
| NO20000519L (no) | 2-acylaminopropanaminer som takykininreseptorantagonister | |
| DK1071433T3 (da) | 2',2'-difluornucleosider til immunosuppressiv behandling og kombinationspræparater | |
| ATE240303T1 (de) | 1,2,4-triazol-3-thion verbindungen | |
| DE69120287D1 (en) | Aminosulfonylharnstoff-acat-inhibitoren | |
| NO971997D0 (no) | Bruk av immunmodulerende midler | |
| DK0838469T3 (da) | 10,13,15-trioxatricyclo(9.2.1 9.6)-pentadecanon-derivater, fremgangsmåde til deres fremstilling og lægemidler indeholdende disse forbindelser | |
| TR200000455T2 (tr) | Alzheimer hastalığının tedavisinde fankinonun kullanılması. | |
| TR200000697T2 (tr) | İkame edilmiş 1,2,3,4,5,6-Heksahidro-2,6-Metano-3-Benzazosin-10-OL'ler, üretim yöntemleri ve farmasötik preparat olarak kullanımları. | |
| MX9708394A (es) | Composicion farmaceutica que contiene clorhidrato de tiagabina y el proceso para su preparacion. | |
| PH31643A (en) | 2-Oxidole-1-carboxamide pharmaceutical agents for the treatment of alzheimer's disease. | |
| HUP9900863A3 (en) | 4,4-(disubstituted)cyclohexan-1-ol derivatives pharmaceutical compositions containing these compounds and use thereof | |
| DE69636837D1 (de) | 1,2,4-benzotriazinoxid-formulierungen | |
| TR199901385T2 (xx) | Piperidin t�revleri. | |
| NO307512B1 (no) | Nye indolforbindelser, farmasøytisk preparat inneholdende slike forbindelser, og deres anvendelse |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |